Why COVID patients who could most benefit from Paxlovid still aren't getting itThe high cost of Paxlovid is a barrier to access for many patients.Low awareness among patients and doctors about Paxlovid's benefits and application process.
Women in England and Wales denied exciting' drug that can stop breast cancer spreadingThousands of women with advanced breast cancer in England and Wales are being denied the drug Enhertu that can reduce the risk of disease spreading by over a third.
Health insurers cover fewer drugs and make them harder to getInsurance formularies are shrinking, covering fewer drugs over the years, leading to hurdles and limited access to prescription drugs.